Skip to content

Drug interactions

Finerenone + Orphenadrin

Severity: Minor

Finerenone and Orphenadrin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Finerenone is metabolized mainly by CYP3A4, and orphenadrine is reported as a weak CYP3A4 inhibitor. Higher finerenone exposure could increase the risk of hyperkalemia and renal effects, although the expected increase is modest.

What this interaction means in plain words

Finerenone and Orphenadrin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Finerenone belongs to Cardiovascular; Orphenadrin belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Possible weak inhibition of CYP3A4-mediated finerenone metabolism.

What to do

Check serum potassium and renal function after starting or changing orphenadrine in patients on finerenone. Adjust finerenone dose according to potassium results.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Finerenone and Orphenadrin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Finerenone with Orphenadrin?

MediHelp rates the interaction as minor. Finerenone and Orphenadrin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Finerenone is metabolized mainly by CYP3A4, and orphenadrine is reported as a weak CYP3A4 inhibitor. Higher finerenone exposure could increase the risk of hyperkalemia and renal effects, although the expected increase is modest.

How serious is the interaction between Finerenone and Orphenadrin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check serum potassium and renal function after starting or changing orphenadrine in patients on finerenone. Adjust finerenone dose according to potassium results.

What other medicines interact with Orphenadrin?

MediHelp also lists interactions of Orphenadrin with, for example, Alfentanil, Amobarbital, Benzhydrocodone / acetaminophen. The full list is on the Orphenadrin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in